Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Abrocitinib for Atopic Dermatitis – Drug Topics,

The drug’s approval was based on the results of 3 clinical trials. On January 14, 2022, the FDA approved abrocitinib (Cibinqo) for the treat- ment …, The drug’s approval was based on the results of 3 clinical trials. On January 14, 2022, the FDA approved abrocitinib (Cibinqo) for the treat- ment …, Read More

Scroll to Top